Making Sense with Sam Harris #337 — The Future of Psychedelic Medicine
64 snips
Oct 4, 2023 
Jeannie Fontana, MD-PhD, a trailblazer in healthcare and ALS research funding, joins Robin Carhart-Harris, the founder of the Center for Psychedelic Research. They explore the TREAT Initiative in California, aiming to secure vital funding for psychedelic treatments in mental health. The conversation covers the legal landscape for psychedelics, the importance of safe therapeutic practices, and ongoing advocacy efforts. They also delve into the neuroscience behind psychedelics, discussing their potential for treating conditions like PTSD and their impact on brain function.
AI Snips
Chapters
Books
Transcript
Episode notes
Jeannie's Journey into Healthcare Advocacy
- Jeannie Fontana's mother was diagnosed with ALS, motivating her to change federal legislation and increase funding for research.
- She also played a pivotal role in creating the California Institute of Regenerative Medicine (CIRM), the world's largest stem cell granting agency.
Robin's Path to Psychedelic Research
- Robin Carhart-Harris's interest in psychology led him to study the serotonin system and psychedelics' use in psychotherapy.
- He founded the Center for Psychedelic Research at Imperial College London and has led numerous neuroimaging and clinical trials.
Support TREAT California
- Support the TREAT California campaign by signing the petition at treatcalifornia.org. Registered California voters' signatures are crucial for the initiative's success.
